Your browser does not support JavaScript!
Logo de Labiotech.eu

Labiotech.eu Source d'actualité

Une actualité de Labiotech.eu a été ajouté(e)
Il y a 24 min
Fallouh Healthcare’s device to give early diagnosis for post-surgery strangulation risk
U.K.-based Fallouh Healthcare is developing a device to monitor cardiac patients after surgery, which is when a condition, called cardiac tamponade, can strike. The company says patients recovering...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Aujourd'hui à 12:12
Positive antibody persistence for vaccine treating mosquito disease
A single shot vaccine for mosquito-borne disease chikungunya has had positive antibody persistence data 12 months after vaccination. The primary endpoint also met with a 99% seroresponse rate. The...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Aujourd'hui à 08:34
The biggest private biotech investments in November 2022
The companies Emalex Biosciences, Osler Diagnostics and TauRx Pharmaceuticals bagged the biggest biotech investments in November 2022. Around the world, oncology and cell therapy players attracted the...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 16:57
Creating designer immune cells at scale
To prevent testing on animals and create more precise ways of testing therapeutics, the pharmaceutical industry is turning to human immune cells. However, the availability of cells has been limited to...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 12:12
Partnership to deliver oncology workflow for 7 European hospitals
A BC Platforms (BCP) partnership that includes Finland’s Euformatics and Hungary’s Oncompass Medicine has been awarded a contract for the second phase of developing standardized oncology workflows for...
www.labiotech.eu
Charger plus d'actualités

Informations juridiques
SIREN / SIRET - DE Labiotech

Adresse
Berlin Berlin DE Allemagne